Taipei Medical University

Chien-Hsi Chang

Chia-Hwa Lee

Yuan-Soon Ho

Yu-Jia Chang

Ching-Shyang Chen

Li-Ching Chen

Po-Li Wei

Hui-Wen Chang

Ching-Shui Huang

Shih-Hsin Tu

Chih-Hsiung Wu

Ying-Jan Wang

Ya-Chieh Chang

The invention relates to methods of identifying a candidate compound which may inhibit estrogen receptor-dependent transcription or &#x3b1;9-nAChR overexpression and proliferation of nicotine-derived-compound-induced breast cancer cells by using an activating protein 1 (AP1) polypeptide. The invention found that &#x3b1;9-nAChR has an activating protein 1 (AP1)-binding site, that the &#x3b1;9-nAChR promoter is located at the AP1-binding site, and that ERs specifically bind to the &#x3b1;9-nAChR promoter at the AP1-binding site, indicating that ER-induced &#x3b1;9-nAChR up-regulation plays a central role in the response to endogenous (E2) or exogenous (nicotine) stimulation.

Method of identifying a candidate compound which may inhibit &#x3b1;9-nAchR overexpression or estrogen receptor-dependent transcription in nicotine-derived-compound-induced breast cancer cells

Growing community of inventors

Taipei, Taiwan

Chien-Hsi Chang